Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

被引：0
|
作者：
Christian Zurth
Mikko Koskinen
Robert Fricke
Olaf Prien
Timo Korjamo
Kristina Graudenz
Karsten Denner
Michaela Bairlein
Clemens-Jeremias von Bühler
Gary Wilkinson
Hille Gieschen
机构：
[1] Bayer AG,
[2] Orion Corporation,undefined
[3] Orion Pharma,undefined
[4] Bayer AG,undefined
来源：
European Journal of Drug Metabolism and Pharmacokinetics | 2019年 / 44卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：747 / 759
页数：12
相关论文
共 50 条
  • [31] Is pomegranate juice a potential perpetrator of clinical drug–drug interactions? Review of the in vitro, preclinical and clinical evidence
    Nuggehally R. Srinivas
    European Journal of Drug Metabolism and Pharmacokinetics, 2013, 38 : 223 - 229
  • [32] Impact of valproic acid on busulfan pharmacokinetics: In vitro assessment of potential drug-drug interaction
    Al-Enezi, Bashayer F.
    Al-Hasawi, Nada
    Matar, Kamal M.
    PLOS ONE, 2023, 18 (01):
  • [33] In Vitro Characterization of the Drug-Drug Interaction Potential of Catabolites of Antibody-Maytansinoid Conjugates
    Davis, John A.
    Rock, Dan A.
    Wienkers, Larry C.
    Pearson, Josh T.
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (10) : 1927 - 1934
  • [34] Low drug drug interaction potential of rotigotine
    Hansen, K
    Braun, M
    Horstmann, R
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1091 - 1091
  • [35] Strategies to address drug interaction potential for antibody-drug conjugates in clinical development
    Lu, Dan
    Sahasranaman, Srikumar
    Zhang, Yi
    Girish, Sandhya
    BIOANALYSIS, 2013, 5 (09) : 1115 - 1130
  • [36] Clinical-pharmacological strategies to assess drug interaction potential during drug development
    Kuhlmann, J
    Mück, W
    DRUG SAFETY, 2001, 24 (10) : 715 - 725
  • [37] Clinical Assessment of the Drug-Drug Interaction Potential of Omaveloxolone in Healthy Adult Participants
    Zahir, Hamim
    Murai, Masako
    Wu, Lucy
    Valentine, Michelle
    Hynes, Scott
    JOURNAL OF CLINICAL PHARMACOLOGY, 2025,
  • [38] Clinical-Pharmacological Strategies to Assess Drug Interaction Potential During Drug Development
    Jochen Kuhlmann
    Wolfgang Mück
    Drug Safety, 2001, 24 : 715 - 725
  • [39] Prevalence and clinical significance of potential drug–drug interaction in hematopoietic stem cell transplantation
    Danilo D. Trevisan
    Juliana B. Silva
    Henrique C. Oliveira
    Silvia R. Secoli
    Maria Helena M. Lima
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 393 - 400
  • [40] Clinical Drug–Drug Pharmacokinetic Interaction Potential of Sucralfate with Other Drugs: Review and Perspectives
    Suresh P. Sulochana
    Muzeeb Syed
    Devaraj V. Chandrasekar
    Ramesh Mullangi
    Nuggehally R. Srinivas
    European Journal of Drug Metabolism and Pharmacokinetics, 2016, 41 : 469 - 503
12345